Cargando…

A Randomized, Controlled Comparison of NCX 470 (0.021%, 0.042%, and 0.065%) and Latanoprost 0.005% in Patients With Open-angle Glaucoma or Ocular Hypertension: The Dolomites Study

NCX 470 0.042% and 0.065% were statistically superior in intraocular pressure (IOP) lowering to latanoprost 0.005%, and NCX 470 0.021% was noninferior. All NCX 470 concentrations were safe and well tolerated. PURPOSE: The purpose of this study was to compare varying concentrations of NCX 470 (a nitr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walters, Thomas R., Kothe, Angela C., Boyer, José L., Usner, Dale W., Lopez, Krisol, Duquesroix, Brigitte, Fechtner, Robert D., Navratil, Tomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	New Glaucoma Insights: Original Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148672/ https://www.ncbi.nlm.nih.gov/pubmed/35394456 http://dx.doi.org/10.1097/IJG.0000000000002030

Ejemplares similares

Treatment of a middle cerebral artery bifurcation aneurysm with the novel Contour Neurovascular System compatible with 0.021″ catheters
por: Thormann, Maximilian, et al.
Publicado: (2021)

Evaluation of the microstructure, optical properties and hopping conduction mechanism of rare earth doped Ba(0.85)Ca(0.12)RE(0.03)Ti(0.90)Zr(0.04)Nb(0.042)O(3) ceramics (RE = Ce(3+) and Pr(3+))
por: Bourguiba, M., et al.
Publicado: (2022)

Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
por: Inoue, Kenji, et al.
Publicado: (2012)

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
por: Nakakura, Shunsuke, et al.
Publicado: (2012)

(S)-2-Methylpiperazinediium dichloride 0.42-hydrate
por: Harrison, William T. A.
Publicado: (2008)

Comparing the Efficacy of Latanoprost (0.005%), Bimatoprost (0.03%), Travoprost (0.004%), and Timolol (0.5%) in the Treatment of Primary Open Angle Glaucoma
por: Mishra, Deepak, et al.
Publicado: (2014)

Retract p < 0.005 and propose using JASP, instead
por: Perezgonzalez, Jose D., et al.
Publicado: (2018)

Comparative study of the stability of bimatoprost 0.03% and latanoprost 0.005%: A patient-use study
por: Paolera, Mauricio D, et al.
Publicado: (2008)

The assessment of intrinsic credibility and a new argument for p < 0.005
por: Held, Leonhard
Publicado: (2019)

A randomized crossover study comparing tafluprost 0.005% with travoprost 0.004% in patients with normal-tension glaucoma
por: Mizoguchi, Takanori, et al.
Publicado: (2012)

Study of magnetic and electrical properties of Pr(0.65)Ca(0.25)Ba(0.1)MnO(3) manganite
por: Mleiki, Ali, et al.
Publicado: (2018)

Grain Growth Kinetics of 0.65Ca(0.61)La(0.26)TiO(3)-0.35Sm(Mg(0.5)Ti(0.5))O(3) Dielectric Ceramic
por: Liu, Jin, et al.
Publicado: (2020)

Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients
por: Miyashiro, Michael J, et al.
Publicado: (2010)

Ga(0.35)In(0.65) N(0.02)As(0.08)/GaAs bidirectional light-emitting and light-absorbing heterojunction operating at 1.3 μm
por: Chaqmaqchee, Faten Adel Ismael, et al.
Publicado: (2014)

The Impact of Hydrogenation on Structural and Superconducting Properties of FeTe(0.65)Se(0.35) Single Crystals
por: Bondarenko, Stanislav I., et al.
Publicado: (2021)

Administration of the fixed combination of latanoprost 0.005% and timolol 0.5% in glaucoma patients with an intraocular pressure over 30 mmHg
por: Özkurt, Yelda Buyru, et al.
Publicado: (2009)

Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
por: Molinelli, Elisa, et al.
Publicado: (2020)

Early Effect of 0.005% Estriol Vaginal Gel on Symptoms and Signs of Vulvovaginal Atrophy
por: Lázaro-Carrasco de la Fuente, Jesús, et al.
Publicado: (2022)

Crystal structure of spinel-type Li(0.64)Fe(2.15)Ge(0.21)O(4)
por: Redhammer, Günther J., et al.
Publicado: (2016)

A Temperature-to-Frequency Converter-Based On-Chip Temperature Sensor with an Inaccuracy of +0.65 °C/−0.49 °C
por: Xu, Zicong, et al.
Publicado: (2023)

A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension
por: Rhee, Douglas J, et al.
Publicado: (2008)

Structure and piezo-ferroelectricity relationship study of (K(0.5)Na(0.5))(0.985)La(0.005)NbO(3) epitaxial films deposited on SrTiO(3) by sputtering
por: H´Mŏk, H´Linh, et al.
Publicado: (2017)

Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
por: Inoue, Kenji, et al.
Publicado: (2014)

Free and bound excitonic effects in Al(0.5)Ga(0.5)N/Al(0.35)Ga(0.65)N MQWs with different Si-doping levels in the well layers
por: He, Chenguang, et al.
Publicado: (2015)

Photo-Charging of Li(Ni(0.65)Co(0.15)Mn(0.20))O(2) Lithium-Ion Battery Using Silicon Solar Cells
por: Heo, Seungbum, et al.
Publicado: (2022)

Ultra Uniform Pb(0.865)La(0.09)(Zr(0.65)Ti(0.35))O(3) Thin Films with Tunable Optical Properties Fabricated via Pulsed Laser Deposition
por: Jiang, Shenglin, et al.
Publicado: (2018)

Results of SC proton cavity tests (B = 1 and B = 0.65)
por: Peauger, F et al
Publicado: (2013)

A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
por: Godfrey, David A, et al.
Publicado: (2009)

Crossover randomized study comparing the efficacy and tolerability of preservative-free Tafluprost 0.0015% to Latanoprost 0.005% in patients with primary open-angle glaucoma
por: Hagras, Sherein M, et al.
Publicado: (2021)

Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis
por: Wiedermann, Christian J
Publicado: (2016)

(La(0.65)Sr(0.3))(0.95)FeO(3−δ) perovskite with high oxygen vacancy as efficient bifunctional electrocatalysts for Zn–air batteries
por: Luo, Liyang, et al.
Publicado: (2021)

Magnetic Properties and Magnetocaloric Effect of Polycrystalline and Nano-Manganites Pr(0.65)Sr((0.35−x))Ca(x)MnO(3) (x ≤ 0.3)
por: Atanasov, Roman, et al.
Publicado: (2023)

Request for 160 000 pictures in the 81 cm DBC of $K^{+}$ in the momentum range 0.65 to 0.80 GeV/c
por: CERN. Geneva. Track Chamber Committee
Publicado: (1969)

Improved Efficacy of Topical Latanoprost 0.005% Demonstrated by Corneal Biomechanical Correcting Modified Goldmann Prism
por: Radcliffe, Nathan, et al.
Publicado: (2020)

Direct evidence for a pressure-induced nodal superconducting gap in the Ba(0.65)Rb(0.35)Fe(2)As(2) superconductor
por: Guguchia, Z., et al.
Publicado: (2015)

Domain Meissner state and spontaneous vortex-antivortex generation in the ferromagnetic superconductor EuFe(2)(As(0.79)P(0.21))(2)
por: Stolyarov, Vasily S., et al.
Publicado: (2018)

Band-dependent superconducting gap in SrFe(2)(As(0.65)P(0.35))(2) studied by angle-resolved photoemission spectroscopy
por: Suzuki, H., et al.
Publicado: (2019)

p < 0.05, < 0.01, < 0.001, < 0.0001, < 0.00001, < 0.000001, or < 0.0000001 …
por: Zhu, Weimo
Publicado: (2016)

Tailoring Magnetic Properties of Fe(0.65)Co(0.35) Nanoparticles by Compositing with RE(2)O(3) (RE = La, Nd, and Sm)
por: Djellal, Nacira, et al.
Publicado: (2022)

Copper-doped lanthanum manganite La(0.65)Ce(0.05)Sr(0.3)Mn(1−x)Cu(x)O(3) influence on structural, magnetic and magnetocaloric effects
por: Chebaane, M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r41pit233s7jaitr4hqusgs03t